World BioHazTec

Biosafety is no longer just a laboratory concern.

As biological research becomes more complex, biosafety has become an enterprise risk issue tied to operations, funding, governance, reputation, and long-term resilience.

A biosafety incident doesn’t stay inside the lab. It can disrupt operations, trigger regulatory scrutiny, create legal exposure, and weaken stakeholder trust.

That’s why forward-looking organizations are moving beyond a checklist approach and treating biosafety as part of their broader risk management strategy.

At World BioHazTec, we believe the question is no longer just, “Are we compliant?” It’s: “Are we protected?”

Read our latest blog on why biosafety is becoming a boardroom issue. Link in the comments 👇

From high-containment lab operations to AI in biohazardous research, the future of biosafety is already here.

Join us June 10 for the Chesapeake Area Biological Safety Association's Annual Scientific Symposium, a full day of insight, innovation, and connection with leaders across biosafety, research, and emerging technology.

This year’s program features keynote speakers Kelly Schulz, CEO of the Maryland Tech Council, and Rebecca Bradford, SVP at ATCC, along with technical sessions covering:

🧪 High-containment decontamination challenges
🧪 Risk-based approaches to decontamination
🧪 Airflow mapping in biosafety cabinets
🧪 AI and robotics in biohazardous research
🧪 Biosecurity and risk mitigation in emerging biotech tools

📍 June 10 | Universities at Shady Grove | Rockville, MD
💻 Attend in person or virtually

Register here: https://loom.ly/5zYKe7A